Investment Summary |
|
---|---|
Date | 2024-06-04 |
Target | Sofie Biosciences |
Sector | Life Science |
Investor(s) | Trilantic North America |
Deal Type | Growth Capital |
Advisor(s) | Solomon Partners (Financial) Paul, Weiss, Rifkind, Wharton & Garrison (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 2009 |
PE ASSETS | 9.6B USD |
Size | Mega |
Type | Sector Agnostic |
Trilantic North America is a mega-sized private equity firm focused on opportunities throughout North America. Trilantic generally invests in large businesses with 'strong market positions, unique franchises, secure and growing market niches or distinctive products and services that command premium prices'. Sectors of interest include business services, consumer, energy, and financial services. The Firm's target investment size is $50 to $300 million in companies valued up to $1 billion. Transaction situations of interest include management buyouts, recapitalizations, growth capital financings, divestitures, new platforms, and generational transfers. Trilantic North America was formed in 2009 through the spin-off of Lehman Brothers' private equity business. The Firm is based in New York City.
DEAL STATS | # |
---|---|
Overall | 51 of 51 |
Sector (Life Science) | 1 of 1 |
Type (Growth Capital) | 16 of 16 |
State (Virginia) | 1 of 1 |
Country (United States) | 49 of 49 |
Year (2024) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-08-03 |
TSC Miami
Miami Gardens, Florida, United States TSC Miami is a tech-enabled digital and screen printing and fulfillment platform for apparel and accessories selling into ecommerce, retail and creator end markets. TSC Miami was founded in 2001 and is based in Miami Gardens, Florida. |
Buy | - |